EGFR and breast cancer: Additionally, WBP2 (WW domain-binding protein 2) is an emerging oncogene involved in Wnt, EGFR, Hippo, and PI3K /Akt pathways[45].It was reported that inhibition of WBP2 expression by miR-613 repressed breast cancer growth[46].